These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15144954)

  • 1. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
    Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
    Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response.
    Kurki S; Peltonen K; Laiho M
    Cell Cycle; 2004 Aug; 3(8):976-9. PubMed ID: 15254398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interaction of the TPL2 kinase with nucleophosmin.
    Kanellis DC; Bursac S; Tsichlis PN; Volarevic S; Eliopoulos AG
    Oncogene; 2015 May; 34(19):2516-26. PubMed ID: 24998852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
    Latonen L; Taya Y; Laiho M
    Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
    Lau LM; Nugent JK; Zhao X; Irwin MS
    Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
    Tago K; Chiocca S; Sherr CJ
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
    Ianni A; Kumari P; Tarighi S; Simonet NG; Popescu D; Guenther S; Hölper S; Schmidt A; Smolka C; Yue S; Krüger M; Fiorillo C; Vaquero A; Bober E; Braun T
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
    Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
    Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HDM2 activity by the ribosomal protein L11.
    Lohrum MA; Ludwig RL; Kubbutat MH; Hanlon M; Vousden KH
    Cancer Cell; 2003 Jun; 3(6):577-87. PubMed ID: 12842086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDM2 negatively affects the Chk2-mediated phosphorylation of p53.
    Bjørling-Poulsen M; Meek D; Issinger OG
    FEBS Lett; 2005 May; 579(12):2604-8. PubMed ID: 15862297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDM2 phosphorylation by MAPKAP kinase 2.
    Weber HO; Ludwig RL; Morrison D; Kotlyarov A; Gaestel M; Vousden KH
    Oncogene; 2005 Mar; 24(12):1965-72. PubMed ID: 15688025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
    Jin A; Itahana K; O'Keefe K; Zhang Y
    Mol Cell Biol; 2004 Sep; 24(17):7669-80. PubMed ID: 15314174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
    Gjerset RA
    J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for HDM2 activity in the rapid degradation of p53 in neuroblastoma.
    Isaacs JS; Saito S; Neckers LM
    J Biol Chem; 2001 May; 276(21):18497-506. PubMed ID: 11279110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
    Boyd SD; Tsai KY; Jacks T
    Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
    Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
    Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
    Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.